Technology News and Research

RSS

World's first urine-based tuberculosis diagnostics tool

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostics systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, in a new video today unveiled the world's first urine-based tuberculosis diagnostics tool.

9 May 2011

Viewpoints: Dems' Medicare strategy; Health disparities; Chicago hospital dispute

Democrats may be feeling smug about their campaign against the House Republican budget plan, and as a matter of politics, they're no doubt right. If the goal is to deal with the long-term fiscal challenge, though, the Democrats' political success is apt only to prolong the gridlock and make the eventual solution that much more painful. ...

9 May 2011

First, free EHR vendor earns complete ONC-ATCB meaningful use certification

Mitochon Systems, provider of a free EHR to physician practices, announced today it has earned complete ambulatory EHR certification (ONC-ATCB 2011/2012) from the Drummond Group, Inc.

9 May 2011

Medtronic, Bayer HealthCare expand global alliance to develop next generation diabetes management solutions

Medtronic, Inc. and Bayer HealthCare have expanded their international alliance to now include the United States and will work exclusively to develop innovative next generation diabetes management solutions for patients, state-of-the-art, wireless blood glucose meters worldwide.

From Medtronic 9 May 2011

Novavax first quarter net loss decreases to $7.5 million

Novavax, Inc. today announced its financial results for the first quarter ended March 31, 2011.

9 May 2011

Acousticon receives FDA clearance for ACAM-5 hearing loss product

TCG today announced that Acousticon Inc., one of its portfolio companies, recently received FDA clearance for its ACAM-5 product, allowing the company to begin US commercialization activities for the first time.

9 May 2011

U-Systems completes $6.5 million funding round

U-Systems, Inc., the leader in automated breast ultrasound technology, announced today the completion of a $6.5 million funding round. The additional capital came exclusively from existing U-Systems investors and affiliates including iD SoftCapital Group, Lumira Capital, PIIH, Radius Ventures, and Sycamore Ventures.

9 May 2011

State roundup: Concerns about state employee retirement boom

Plummeting stock portfolios and home values prompted many Baby Boomers to keep working long after retirement age. ... "What was once a planned exit is no longer a planned exit," says Daniel Hackler, Indiana's state personnel director.

9 May 2011

Unigene first quarter net loss decreases 58% to $6.6 million

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced first quarter financial results for the period ended March 31, 2011. The Company highlighted significant progress achieved in the first quarter with the execution of its turnaround strategy.

9 May 2011

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Intrexon Corporation, a next generation synthetic biology company, today announced an agreement with Novici Biotech LLC in which Intrexon has licensed certain non-exclusive rights to the use of Novici's patented GRAMMR® technology for high-resolution genetic reassortment ("gene shuffling").

9 May 2011

Advanced Cell Technology first quarter net loss decreases to $3.3 million

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.

9 May 2011

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

Lovelace Health System, Inc. has signed a definitive agreement to purchase the assets and operations of the Heart Hospital of New Mexico from MedCath Corporation for $119 million.

9 May 2011

IOD announces expanded capabilities to address top health information management challenges

IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, health systems, and physician practices, today announced expanded capabilities to address health information management's top three challenges of this decade: transitioning to ICD-10, implementing electronic records and recruiting highly qualified HIM staff.

9 May 2011

Ellman International launches Pelleve GlideSafe handpieces for wrinkle treatment

Ellman International, Inc., maker of the Pelleve Wrinkle Reduction System, a revolutionary skin tightening system for non-ablative skin rejuvenation, introduced its new family of GlideSafe™ handpieces this week at the American Society for Aesthetic Plastic Surgery's 44th Annual Meeting at the Boston Convention & Exhibition Center.

9 May 2011

Illumina announces price reduction in whole human genome sequencing projects

Illumina, Inc. today announced that it is significantly reducing the price for sequencing whole human genomes through the Illumina Genome Network.

From Illumina, Inc. 9 May 2011

caprotec bioanalytics closes Series B financing for EUR 5 million

caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.

9 May 2011

OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily

OncoSec Medical Inc., a therapeutic oncology company developing innovative medical approaches to treat solid tumor cancers with unmet medical needs, announced today the cancer therapy company's tumor-destroying, tissue-sparing drug/device technology was profiled in Medical Device Daily, the news source for the high-tech medical technology industry that is relied on by thousands of industry insiders every business morning.

9 May 2011

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

Flamel Technologies today announced its financial results for the first quarter of 2011.

9 May 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.

9 May 2011

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Heptares Therapeutics today announced it has signed an exclusive option agreement with Shire Pharmaceuticals for a novel adenosine A2A antagonist discovered by Heptares and currently in preclinical development.

9 May 2011

Technology News and Research

World's first urine-based tuberculosis diagnostics tool

Viewpoints: Dems' Medicare strategy; Health disparities; Chicago hospital dispute

First, free EHR vendor earns complete ONC-ATCB meaningful use certification

Medtronic, Bayer HealthCare expand global alliance to develop next generation diabetes management solutions

Novavax first quarter net loss decreases to $7.5 million

Acousticon receives FDA clearance for ACAM-5 hearing loss product

U-Systems completes $6.5 million funding round

State roundup: Concerns about state employee retirement boom

Unigene first quarter net loss decreases 58% to $6.6 million

Intrexon to deploy Novici's GRAMMR technology in concert with UltraVector platform

Advanced Cell Technology first quarter net loss decreases to $3.3 million

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

IOD announces expanded capabilities to address top health information management challenges

Ellman International launches Pelleve GlideSafe handpieces for wrinkle treatment

Illumina announces price reduction in whole human genome sequencing projects

caprotec bioanalytics closes Series B financing for EUR 5 million

OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News